Targeted radioligand therapy in oncology: clinical development across targets and platforms.
- DOI
- 10.3389/fonc.2026.1886049
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1886049,
title = {Targeted radioligand therapy in oncology: clinical development across targets and platforms.},
author = {An J and Meng X and Hathout L and Ennis R and Zhang X and Yue NJ and Deek MP and Jabbour SK},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1886049},
url = {https://doi.org/10.3389/fonc.2026.1886049}
}RIS
TY - JOUR TI - Targeted radioligand therapy in oncology: clinical development across targets and platforms. AU - An J AU - Meng X AU - Hathout L AU - Ennis R AU - Zhang X AU - Yue NJ AU - Deek MP AU - Jabbour SK PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1886049 UR - https://doi.org/10.3389/fonc.2026.1886049 ER -
APA
J, A., X, M., L, H., R, E., X, Z., NJ, Y., MP, D., & SK, J. (2026). Targeted radioligand therapy in oncology: clinical development across targets and platforms.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1886049